Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rasagiline preparation and preparation method thereof

A technology of rasagiline pharmacy and preparation, which is applied in the direction of pharmaceutical formulas, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc. It can solve the problems of unsatisfactory stability of rasagiline preparations and achieve Low cost, improved dissolution rate and stability, and guaranteed content uniformity

Active Publication Date: 2013-09-25
SHANGHAI ZHONGXI PHARMA
View PDF6 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] The technical problem to be solved by the present invention is to provide a rasagiline preparation with excellent stability and lower content of related substances and its preparation method in order to overcome the unsatisfactory defect of existing rasagiline preparations.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rasagiline preparation and preparation method thereof
  • Rasagiline preparation and preparation method thereof
  • Rasagiline preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1 and 2

[0051] Embodiment 1 and 2 rasagiline mesylate tablet (1mg / tablet) (unit: gram)

[0052]

[0053]

[0054] Example 1 The concentration of buffered water solution is 3.1%, and the pH value is about 3.1.

[0055] Example 2 The concentration of buffered water solution is 3.1%, and the pH value is about 3.1.

Embodiment 3

[0058] Example 3 The concentration of buffered water solution is 1.9%, and the pH value is about 1.9.

Embodiment 4

[0059] Example 4 The concentration of buffered water solution is 3.9%, and the pH value is about 2.9.

[0060] Embodiment 5 and 6 rasagiline mesylate tablet (1mg / tablet) (unit: gram)

[0061]

[0062]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a rasagiline preparation and a preparation method thereof. The rasagiline preparation provided by the invention comprises rasagiline pharmaceutically acceptable salt and pharmaceutically acceptable auxiliary materials comprising a stabilizer and a filling agent. With the method provided by the invention, dissolution rate and stability of the rasagiline preparation are improved, preparation content uniformity is ensured, treatments of crushing and sieving are avoided, and loss and pollution are reduced. The method also has the advantages of simple operation, low cost, and no requirement on special equipment. The method is suitable to be applied on industrial productions.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a rasagiline preparation and a preparation method thereof. Background technique [0002] Parkinson's disease (PD), also known as Parkinson's disease, is the second most common neurodegenerative disease after Alzheimer's disease. Its two characteristic pathological signs-the selective death of a large number of dopaminergic neurons in the substantia nigra compacta and the existence of Lewy bodies in the remaining neurons-are the root of the clinical symptoms. Although the etiology of Parkinson's disease is unclear, its important physiological basis is the imbalance between central neurotransmitters caused by the decrease of dopamine and the relative increase of acetylcholine. The etiology of Parkinson's disease may involve aging, genetic and environmental factors, etc. [0003] The chemical name of rasagiline: (1R)-2,3-dihydro-N-2-propynyl-1H-inden-1-amine,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/135A61K47/12A61K47/02A61P25/16
Inventor 郑斯骥刘潇怡袁少卿
Owner SHANGHAI ZHONGXI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com